News
Lieff Cabraser Announces Class Action Litigation Against Intuitive Surgical, Inc.
May 14, 2013 9:00 am | by The Associated Press | CommentsSAN FRANCISCO--(BUSINESS WIRE)--May 14, 2013--The law firm of Lieff Cabraser Heimann & Bernstein, LLP announces that class action litigation has been brought on behalf of all persons who purchased or otherwise acquired the securities of Intuitive Surgical, Inc. (“Intuitive” or the “Company”)...
NVISION Laser Eye Centers First in the Nation to Offer Avellino-GENE Detection System Test to Protect Patients from Blindness
May 14, 2013 8:04 am | by PR Newswire | CommentsMENLO PARK, Calif., May 14, 2013 /PRNewswire/ -- Avellino Lab USA, developer of the only genetic test available worldwide for Avellino Corneal Dystrophy (ACD), today announced that California-based NVISION Laser Eye Centers is the first provider in the United States to offer patients...
Vocera® Ranked Number One in Wireless Communications for Healthcare
May 14, 2013 8:03 am | by PR Newswire | CommentsSAN JOSE, Calif., May 14, 2013 /PRNewswire/ -- Vocera Communications, Inc. (NYSE: VCRA), the leading provider of solutions that address critical communications and productivity challenges facing healthcare, hospitality, retail and other mobile work environments, today announced findings...
St. Jude Medical Announces First Patient Enrollment in EnligHTN III Renal Denervation Study of Next-Generation EnligHTN System
May 14, 2013 8:00 am | by The Associated Press | CommentsST. PAUL, Minn.--(BUSINESS WIRE)--May 14, 2013--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced enrollment of the first patient in the EnligHTN III trial. This study will evaluate the safety and performance of the new second-generation EnligHTN ™ Renal...
The University of Sydney and ResMed partner to accelerate research in sleep-disordered breathing and biomedical engineering
May 13, 2013 4:30 pm | by PR Newswire | CommentsSYDNEY, May 13, 2013 /PRNewswire/ -- The University of Sydney and ResMed Limited today announced a new partnership that includes significant and long-term funding of research at the University, ultimately benefitting the hundreds of millions of sufferers of sleep-disordered breathing worldwide.
Breakthrough ‘AffloVest’ Greatly Advances Respiratory Care
May 13, 2013 1:46 pm | by International Biophysics Corporation | CommentsA new high frequency chest wall oscillation vest that gives respiratory patients the freedom to move around during treatments is now available in the United States, International Biophysics Corporation has announced. The AffloVest represents a major advancement in the treatment of respiratory diseases such as Chronic Obstructive Pulmonary Disease, Cystic Fibrosis, chronic bronchitis, and similar related ailments.
Anaesthetists’ Survey Delivers Food for Thought
May 13, 2013 1:23 pm | by Creative Medical Research | CommentsA recent Europe-wide survey of Anaesthetists has revealed a range of issues affecting the profession in relation to existing and future technologies. The 15-minute long survey of 104 anaesthetists from western, northern and southern Europe asked a number of pertinent questions concerning the nature of current technologies and those expected to come on stream in the near future.
The Smart Phone App that Helps Weight Loss
May 13, 2013 12:28 pm | by The University of Liverpool | CommentsResearchers at the University of Liverpool have developed a smart phone app that helps users lose weight by carefully recording their food consumption. The app was developed in response to research from the University’s Institute of Psychology, Health and Society, which showed that paying attention to what you eat while you eat it helps reduce food intake and prevents consuming excess calories at future meals.
Extremely Low 90-Day Cardiac Device Infection Rates with TYRX Antibacterial Envelope Use
May 13, 2013 12:19 pm | by Kureczka/Martin Associates | CommentsUse of TYRX, Inc.'s AIGISRx Antibacterial Envelope reduced major infection rates by more than 90% in patients undergoing Cardiovascular Implantable Electronic Device (CIED) replacement procedures compared to similar high-risk cohorts, according to the CITADEL & CENTURION clinical study results presented on Saturday at the Late Breaking Clinical Trials session at Heart Rhythm 2013.
Reversing Paralysis with a Restorative Gel
May 13, 2013 12:15 pm | by Tel Aviv University | CommentsSome parts of the body, like the liver, can regenerate themselves after damage. But others, such as our nervous system, are considered either irreparable or slow to recover, leaving thousands with a lifetime of pain, limited mobility, or even paralysis.
BioControl Medical Launches New Website to Deepen Patient, Family, Clinician Education on Its Investigational CardioFit® Therapy
May 13, 2013 11:47 am | by The Associated Press | CommentsYEHUD, Israel & NEW HOPE, Minn.--(BUSINESS WIRE)--May 13, 2013--BioControl Medical has unveiled a new corporate website that offers patients, family and clinicians a valuable educational resource on its CardioFit therapy for heart failure (HF), as well as the INOVATE-HF (INcrease Of VAgal TonE...
PatientsLikeMe and CISCRP Team up with Sanofi to Spotlight Medical Heroes and Clinical Trial Participation
May 13, 2013 10:00 am | by The Associated Press | CommentsCAMBRIDGE, Mass.--(BUSINESS WIRE)--May 13, 2013--PatientsLikeMe and the nonprofit Center for Information and Study on Clinical Research Participation (CISCRP) announce a new partnership with global healthcare leader Sanofi (NYSE: SNY) to raise awareness about the benefits of participating in...
Biventricular Pacing Reduces Symptoms and Improves Quality-of-Life
May 13, 2013 9:52 am | by Medtronic | CommentsMedtronic has announced new data demonstrating that simultaneously pacing the lower chambers of the heart, or biventricular (BiV) pacing with a cardiac resynchronization therapy (CRT) device, significantly improves heart failure symptoms and quality of life in a subset of heart failure patients.
New Clinical Studies Presented at the International Anesthesia Research Society Annual Meeting Show Benefits of Masimo Noninvasive Patient Monitoring Technologies: SpHb®, RRa™, and SedLine®
May 13, 2013 8:00 am | by PR Newswire | CommentsIRVINE, Calif., May 13, 2013 /PRNewswire/ -- Masimo (NASDAQ: MASI) announced today that three new clinical studies evaluating Masimo noninvasive patient monitoring technologies were presented before the world's leading anesthesia educators and investigators at the International...
Invuity® Finalist for the 2013 Red Herring Top 100 North America Award
May 13, 2013 8:00 am | by PR Newswire | CommentsSAN FRANCISCO, May 13, 2013 /PRNewswire/ -- Invuity®, a leading developer of advanced visualization devices to optimize minimal access and minimally invasive surgeries, announced today it has been selected as a finalist for Red Herring's Top 100 North America award, a...
